Clinical Trial Update: A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both [Phase 1]

View source ↗

Summary

Phase 1 study of the MVA85A TB vaccine in asymptomatic volunteers infected with HIV, TB, or both has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: HIV Infections, TB | Phase 1 | Status: COMPLETED